APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nicotinamide Riboside Malate

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nicotinamide Riboside Malate Market Outlook and Growth Opportunities 2026

19 December 2025198 pages

Choose your research edition.

Industry ResearchNicotinamide Riboside Malate Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Nicotinamide Riboside Malate Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Nicotinamide Riboside Malate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nicotinamide Riboside Malate Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Nicotinamide Riboside Malate Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Nicotinamide Riboside Malate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nicotinamide Riboside Malate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nicotinamide Riboside Malate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nicotinamide Riboside Malate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nicotinamide Riboside Malate market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nicotinamide Riboside Malate market include Invertin Biotech, Xi'an Prius Biological Engineering Co.,Ltd, Shenzhen Hygieia Biotechnology Co., Ltd, Sihuan Pharmaceutical Holdings Group Ltd., NANJING NUOYUN BIOTECHNOLOGY CO.,LTD., Hubei Yanke Times Technology Co., Ltd., Wuhan Hanxiang Biotechnology Co., Ltd., Bontac Bio-Engineering (Shenzhen) Co., Ltd. and Xi'an Chen Lang Biological Technology Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nicotinamide Riboside Malate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nicotinamide Riboside Malate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nicotinamide Riboside Malate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nicotinamide Riboside Malate market size, projected growth trends, production technologies, key applications, and end-use industries.

Nicotinamide Riboside Malate Segment by Company

Invertin Biotech

Xi'an Prius Biological Engineering Co.,Ltd

Shenzhen Hygieia Biotechnology Co., Ltd

Sihuan Pharmaceutical Holdings Group Ltd.

NANJING NUOYUN BIOTECHNOLOGY CO.,LTD.

Hubei Yanke Times Technology Co., Ltd.

Wuhan Hanxiang Biotechnology Co., Ltd.

Bontac Bio-Engineering (Shenzhen) Co., Ltd.

Xi'an Chen Lang Biological Technology Co., Ltd.

Wuhan Fortuna Chemical Co.,Ltd

Lucerna-Chem AG

Gihi Chemicals

Creative Enzymes

Bicells Science Ltd

Nicotinamide Riboside Malate Segment by Type

Purity: Greater than 99%

Purity: Less than 99%

Nicotinamide Riboside Malate Segment by Application

Nutritional Supplements

Research

Other

Nicotinamide Riboside Malate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nicotinamide Riboside Malate status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Nicotinamide Riboside Malate market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nicotinamide Riboside Malate significant trends, drivers, influence factors in global and regions.

6. To analyze Nicotinamide Riboside Malate competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Riboside Malate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nicotinamide Riboside Malate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinamide Riboside Malate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nicotinamide Riboside Malate market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nicotinamide Riboside Malate industry.

Chapter 3: Detailed analysis of Nicotinamide Riboside Malate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Nicotinamide Riboside Malate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Nicotinamide Riboside Malate in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nicotinamide Riboside Malate Industry Trends Table 2. Nicotinamide Riboside Malate Industry Drivers Table 3. Nicotinamide Riboside Malate Industry Opportunities and Challenges Table 4. Nicotinamide Riboside Malate Industry Restraints Table 5. Global Nicotinamide Riboside Malate Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nicotinamide Riboside Malate Revenue Share by Company (2021-2026) Table 7. Global Nicotinamide Riboside Malate Sales Volume by Company (t) & (2021-2026) Table 8. Global Nicotinamide Riboside Malate Sales Volume Share by Company (2021-2026) Table 9. Global Nicotinamide Riboside Malate Average Price (USD/t) of Company (2021-2026) Table 10. Global Nicotinamide Riboside Malate Company Ranking, (2024-2026) & (USD Million) Table 11. Global Nicotinamide Riboside Malate Key Company Manufacturing Base & Headquarters Table 12. Global Nicotinamide Riboside Malate Company, Product Type & Application Table 13. Global Nicotinamide Riboside Malate Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Nicotinamide Riboside Malate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Purity: Greater than 99% Table 18. Significant Companies of Purity: Less than 99% Table 19. Global Nicotinamide Riboside Malate Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 20. Global Nicotinamide Riboside Malate Sales Volume by Type (2021-2026) & (t) Table 21. Global Nicotinamide Riboside Malate Sales Volume by Type (2027-2032) & (t) Table 22. Global Nicotinamide Riboside Malate Sales Volume Share by Type (2021-2026) Table 23. Global Nicotinamide Riboside Malate Sales Volume Share by Type (2027-2032) Table 24. Global Nicotinamide Riboside Malate Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Nicotinamide Riboside Malate Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Nicotinamide Riboside Malate Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Nicotinamide Riboside Malate Sales Value Share by Type (2021-2026) Table 28. Global Nicotinamide Riboside Malate Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Nutritional Supplements Table 30. Significant Companies of Research Table 31. Significant Companies of Other Table 32. Global Nicotinamide Riboside Malate Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 33. Global Nicotinamide Riboside Malate Sales Volume by Application (2021-2026) & (t) Table 34. Global Nicotinamide Riboside Malate Sales Volume by Application (2027-2032) & (t) Table 35. Global Nicotinamide Riboside Malate Sales Volume Share by Application (2021-2026) Table 36. Global Nicotinamide Riboside Malate Sales Volume Share by Application (2027-2032) Table 37. Global Nicotinamide Riboside Malate Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Nicotinamide Riboside Malate Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Nicotinamide Riboside Malate Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Nicotinamide Riboside Malate Sales Value Share by Application (2021-2026) Table 41. Global Nicotinamide Riboside Malate Sales Value Share by Application (2027-2032) Table 42. Global Nicotinamide Riboside Malate Sales by Region: 2021 VS 2025 VS 2032 (t) Table 43. Global Nicotinamide Riboside Malate Sales by Region (2021-2026) & (t) Table 44. Global Nicotinamide Riboside Malate Sales Market Share by Region (2021-2026) Table 45. Global Nicotinamide Riboside Malate Sales by Region (2027-2032) & (t) Table 46. Global Nicotinamide Riboside Malate Sales Market Share by Region (2027-2032) Table 47. Global Nicotinamide Riboside Malate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Nicotinamide Riboside Malate Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Nicotinamide Riboside Malate Sales Value Share by Region (2021-2026) Table 50. Global Nicotinamide Riboside Malate Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Nicotinamide Riboside Malate Sales Value Share by Region (2027-2032) Table 52. Global Nicotinamide Riboside Malate Market Average Price (USD/t) by Region (2021-2026) Table 53. Global Nicotinamide Riboside Malate Market Average Price (USD/t) by Region (2027-2032) Table 54. Global Nicotinamide Riboside Malate Sales by Country: 2021 VS 2025 VS 2032 (t) Table 55. Global Nicotinamide Riboside Malate Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Nicotinamide Riboside Malate Sales by Country (2021-2026) & (t) Table 57. Global Nicotinamide Riboside Malate Sales Market Share by Country (2021-2026) Table 58. Global Nicotinamide Riboside Malate Sales by Country (2027-2032) & (t) Table 59. Global Nicotinamide Riboside Malate Sales Market Share by Country (2027-2032) Table 60. Global Nicotinamide Riboside Malate Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Nicotinamide Riboside Malate Sales Value Market Share by Country (2021-2026) Table 62. Global Nicotinamide Riboside Malate Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Nicotinamide Riboside Malate Sales Value Market Share by Country (2027-2032) Table 64. Invertin Biotech Company Information Table 65. Invertin Biotech Business Overview Table 66. Invertin Biotech Nicotinamide Riboside Malate Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 67. Invertin Biotech Nicotinamide Riboside Malate Product Portfolio Table 68. Invertin Biotech Recent Development Table 69. Xi'an Prius Biological Engineering Co.,Ltd Company Information Table 70. Xi'an Prius Biological Engineering Co.,Ltd Business Overview Table 71. Xi'an Prius Biological Engineering Co.,Ltd Nicotinamide Riboside Malate Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 72. Xi'an Prius Biological Engineering Co.,Ltd Nicotinamide Riboside Malate Product Portfolio Table 73. Xi'an Prius Biological Engineering Co.,Ltd Recent Development Table 74. Shenzhen Hygieia Biotechnology Co., Ltd Company Information Table 75. Shenzhen Hygieia Biotechnology Co., Ltd Business Overview Table 76. Shenzhen Hygieia Biotechnology Co., Ltd Nicotinamide Riboside Malate Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 77. Shenzhen Hygieia Biotechnology Co., Ltd Nicotinamide Riboside Malate Product Portfolio Table 78. Shenzhen Hygieia Biotechnology Co., Ltd Recent Development Table 79. Sihuan Pharmaceutical Holdings Group Ltd. Company Information Table 80. Sihuan Pharmaceutical Holdings Group Ltd. Business Overview Table 81. Sihuan Pharmaceutical Holdings Group Ltd. Nicotinamide Riboside Malate Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 82. Sihuan Pharmaceutical Holdings Group Ltd. Nicotinamide Riboside Malate Product Portfolio Table 83. Sihuan Pharmaceutical Holdings Group Ltd. Recent Development Table 84. NANJING NUOYUN BIOTECHNOLOGY CO.,LTD. Company Information Table 85. NANJING NUOYUN BIOTECHNOLOGY CO.,LTD. Business Overview Table 86. NANJING NUOYUN BIOTECHNOLOGY CO.,LTD. Nicotinamide Riboside Malate Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 87. NANJING NUOYUN BIOTECHNOLOGY CO.,LTD. Nicotinamide Riboside Malate Product Portfolio Table 88. NANJING NUOYUN BIOTECHNOLOGY CO.,LTD. Recent Development Table 89. Hubei Yanke Times Technology Co., Ltd. Company Information Table 90. Hubei Yanke Times Technology Co., Ltd. Business Overview Table 91. Hubei Yanke Times Technology Co., Ltd. Nicotinamide Riboside Malate Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 92. Hubei Yanke Times Technology Co., Ltd. Nicotinamide Riboside Malate Product Portfolio Table 93. Hubei Yanke Times Technology Co., Ltd. Recent Development Table 94. Wuhan Hanxiang Biotechnology Co., Ltd. Company Information Table 95. Wuhan Hanxiang Biotechnology Co., Ltd. Business Overview Table 96. Wuhan Hanxiang Biotechnology Co., Ltd. Nicotinamide Riboside Malate Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 97. Wuhan Hanxiang Biotechnology Co., Ltd. Nicotinamide Riboside Malate Product Portfolio Table 98. Wuhan Hanxiang Biotechnology Co., Ltd. Recent Development Table 99. Bontac Bio-Engineering (Shenzhen) Co., Ltd. Company Information Table 100. Bontac Bio-Engineering (Shenzhen) Co., Ltd. Business Overview Table 101. Bontac Bio-Engineering (Shenzhen) Co., Ltd. Nicotinamide Riboside Malate Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 102. Bontac Bio-Engineering (Shenzhen) Co., Ltd. Nicotinamide Riboside Malate Product Portfolio Table 103. Bontac Bio-Engineering (Shenzhen) Co., Ltd. Recent Development Table 104. Xi'an Chen Lang Biological Technology Co., Ltd. Company Information Table 105. Xi'an Chen Lang Biological Technology Co., Ltd. Business Overview Table 106. Xi'an Chen Lang Biological Technology Co., Ltd. Nicotinamide Riboside Malate Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 107. Xi'an Chen Lang Biological Technology Co., Ltd. Nicotinamide Riboside Malate Product Portfolio Table 108. Xi'an Chen Lang Biological Technology Co., Ltd. Recent Development Table 109. Wuhan Fortuna Chemical Co.,Ltd Company Information Table 110. Wuhan Fortuna Chemical Co.,Ltd Business Overview Table 111. Wuhan Fortuna Chemical Co.,Ltd Nicotinamide Riboside Malate Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 112. Wuhan Fortuna Chemical Co.,Ltd Nicotinamide Riboside Malate Product Portfolio Table 113. Wuhan Fortuna Chemical Co.,Ltd Recent Development Table 114. Lucerna-Chem AG Company Information Table 115. Lucerna-Chem AG Business Overview Table 116. Lucerna-Chem AG Nicotinamide Riboside Malate Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 117. Lucerna-Chem AG Nicotinamide Riboside Malate Product Portfolio Table 118. Lucerna-Chem AG Recent Development Table 119. Gihi Chemicals Company Information Table 120. Gihi Chemicals Business Overview Table 121. Gihi Chemicals Nicotinamide Riboside Malate Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 122. Gihi Chemicals Nicotinamide Riboside Malate Product Portfolio Table 123. Gihi Chemicals Recent Development Table 124. Creative Enzymes Company Information Table 125. Creative Enzymes Business Overview Table 126. Creative Enzymes Nicotinamide Riboside Malate Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 127. Creative Enzymes Nicotinamide Riboside Malate Product Portfolio Table 128. Creative Enzymes Recent Development Table 129. Bicells Science Ltd Company Information Table 130. Bicells Science Ltd Business Overview Table 131. Bicells Science Ltd Nicotinamide Riboside Malate Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 132. Bicells Science Ltd Nicotinamide Riboside Malate Product Portfolio Table 133. Bicells Science Ltd Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Nicotinamide Riboside Malate Distributors List Table 137. Nicotinamide Riboside Malate Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Nicotinamide Riboside Malate Product Image Figure 2. Global Nicotinamide Riboside Malate Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nicotinamide Riboside Malate Sales Value (2021-2032) & (US$ Million) Figure 4. Global Nicotinamide Riboside Malate Sales (2021-2032) & (t) Figure 5. Global Nicotinamide Riboside Malate Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Nicotinamide Riboside Malate Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity: Greater than 99% Image Figure 10. Purity: Less than 99% Image Figure 11. Global Nicotinamide Riboside Malate Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 12. Global Nicotinamide Riboside Malate Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Nicotinamide Riboside Malate Sales Volume Share by Type (2021-2032) Figure 14. Global Nicotinamide Riboside Malate Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Nicotinamide Riboside Malate Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Nicotinamide Riboside Malate Sales Value Share by Type (2021-2032) Figure 17. Nutritional Supplements Image Figure 18. Research Image Figure 19. Other Image Figure 20. Global Nicotinamide Riboside Malate Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 21. Global Nicotinamide Riboside Malate Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Nicotinamide Riboside Malate Sales Volume Share by Application (2021-2032) Figure 23. Global Nicotinamide Riboside Malate Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Nicotinamide Riboside Malate Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Nicotinamide Riboside Malate Sales Value Share by Application (2021-2032) Figure 26. Global Nicotinamide Riboside Malate Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 27. Global Nicotinamide Riboside Malate Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Nicotinamide Riboside Malate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Nicotinamide Riboside Malate Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Nicotinamide Riboside Malate Sales Value (2021-2032) & (US$ Million) Figure 31. North America Nicotinamide Riboside Malate Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Nicotinamide Riboside Malate Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Nicotinamide Riboside Malate Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Nicotinamide Riboside Malate Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Nicotinamide Riboside Malate Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Nicotinamide Riboside Malate Sales Value (2021-2032) & (US$ Million) Figure 37. South America Nicotinamide Riboside Malate Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Nicotinamide Riboside Malate Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Nicotinamide Riboside Malate Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Nicotinamide Riboside Malate Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Nicotinamide Riboside Malate Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Purity: Greater than 99%
  • Purity: Less than 99%
Applications
  • Nutritional Supplements
  • Research
  • Other
Companies covered
  • Invertin Biotech
  • Xi'an Prius Biological Engineering Co.,Ltd
  • Shenzhen Hygieia Biotechnology Co., Ltd
  • Sihuan Pharmaceutical Holdings Group Ltd.
  • NANJING NUOYUN BIOTECHNOLOGY CO.,LTD.
  • Hubei Yanke Times Technology Co., Ltd.
  • Wuhan Hanxiang Biotechnology Co., Ltd.
  • Bontac Bio-Engineering (Shenzhen) Co., Ltd.
  • Xi'an Chen Lang Biological Technology Co., Ltd.
  • Wuhan Fortuna Chemical Co.,Ltd
  • Lucerna-Chem AG
  • Gihi Chemicals
  • Creative Enzymes
  • Bicells Science Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nicotinamide Riboside Malate Sales Value (2021-2032)
  4. 1.2.2 Global Nicotinamide Riboside Malate Sales Volume (2021-2032)
  5. 1.2.3 Global Nicotinamide Riboside Malate Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Nicotinamide Riboside Malate Market Dynamics
  1. 2.1 Nicotinamide Riboside Malate Industry Trends
  2. 2.2 Nicotinamide Riboside Malate Industry Drivers
  3. 2.3 Nicotinamide Riboside Malate Industry Opportunities and Challenges
  4. 2.4 Nicotinamide Riboside Malate Industry Restraints
3 Nicotinamide Riboside Malate Market by Company
  1. 3.1 Global Nicotinamide Riboside Malate Company Revenue Ranking in 2025
  2. 3.2 Global Nicotinamide Riboside Malate Revenue by Company (2021-2026)
  3. 3.3 Global Nicotinamide Riboside Malate Sales Volume by Company (2021-2026)
  4. 3.4 Global Nicotinamide Riboside Malate Average Price by Company (2021-2026)
  5. 3.5 Global Nicotinamide Riboside Malate Company Ranking (2024-2026)
  6. 3.6 Global Nicotinamide Riboside Malate Company Manufacturing Base and Headquarters
  7. 3.7 Global Nicotinamide Riboside Malate Company Product Type and Application
  8. 3.8 Global Nicotinamide Riboside Malate Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Nicotinamide Riboside Malate Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Nicotinamide Riboside Malate Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Nicotinamide Riboside Malate Market by Type
  1. 4.1 Nicotinamide Riboside Malate Type Introduction
  2. 4.1.1 Purity: Greater than 99%
  3. 4.1.2 Purity: Less than 99%
  4. 4.2 Global Nicotinamide Riboside Malate Sales Volume by Type
  5. 4.2.1 Global Nicotinamide Riboside Malate Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Nicotinamide Riboside Malate Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Nicotinamide Riboside Malate Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Nicotinamide Riboside Malate Sales Value by Type
  9. 4.3.1 Global Nicotinamide Riboside Malate Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Nicotinamide Riboside Malate Sales Value by Type (2021-2032)
  11. 4.3.3 Global Nicotinamide Riboside Malate Sales Value Share by Type (2021-2032)
5 Nicotinamide Riboside Malate Market by Application
  1. 5.1 Nicotinamide Riboside Malate Application Introduction
  2. 5.1.1 Nutritional Supplements
  3. 5.1.2 Research
  4. 5.1.3 Other
  5. 5.2 Global Nicotinamide Riboside Malate Sales Volume by Application
  6. 5.2.1 Global Nicotinamide Riboside Malate Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nicotinamide Riboside Malate Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Nicotinamide Riboside Malate Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Nicotinamide Riboside Malate Sales Value by Application
  10. 5.3.1 Global Nicotinamide Riboside Malate Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Nicotinamide Riboside Malate Sales Value by Application (2021-2032)
  12. 5.3.3 Global Nicotinamide Riboside Malate Sales Value Share by Application (2021-2032)
6 Nicotinamide Riboside Malate Regional Sales and Value Analysis
  1. 6.1 Global Nicotinamide Riboside Malate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nicotinamide Riboside Malate Sales by Region (2021-2032)
  3. 6.2.1 Global Nicotinamide Riboside Malate Sales by Region: 2021-2026
  4. 6.2.2 Global Nicotinamide Riboside Malate Sales by Region (2027-2032)
  5. 6.3 Global Nicotinamide Riboside Malate Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Nicotinamide Riboside Malate Sales Value by Region (2021-2032)
  7. 6.4.1 Global Nicotinamide Riboside Malate Sales Value by Region: 2021-2026
  8. 6.4.2 Global Nicotinamide Riboside Malate Sales Value by Region (2027-2032)
  9. 6.5 Global Nicotinamide Riboside Malate Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Nicotinamide Riboside Malate Sales Value (2021-2032)
  12. 6.6.2 North America Nicotinamide Riboside Malate Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Nicotinamide Riboside Malate Sales Value (2021-2032)
  15. 6.7.2 Europe Nicotinamide Riboside Malate Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Nicotinamide Riboside Malate Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Nicotinamide Riboside Malate Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Nicotinamide Riboside Malate Sales Value (2021-2032)
  21. 6.9.2 South America Nicotinamide Riboside Malate Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Nicotinamide Riboside Malate Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Nicotinamide Riboside Malate Sales Value Share by Country, 2025 VS 2032
7 Nicotinamide Riboside Malate Country-level Sales and Value Analysis
  1. 7.1 Global Nicotinamide Riboside Malate Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nicotinamide Riboside Malate Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Nicotinamide Riboside Malate Sales by Country (2021-2032)
  4. 7.3.1 Global Nicotinamide Riboside Malate Sales by Country (2021-2026)
  5. 7.3.2 Global Nicotinamide Riboside Malate Sales by Country (2027-2032)
  6. 7.4 Global Nicotinamide Riboside Malate Sales Value by Country (2021-2032)
  7. 7.4.1 Global Nicotinamide Riboside Malate Sales Value by Country (2021-2026)
  8. 7.4.2 Global Nicotinamide Riboside Malate Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Nicotinamide Riboside Malate Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Nicotinamide Riboside Malate Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Nicotinamide Riboside Malate Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Invertin Biotech
  2. 8.1.1 Invertin Biotech Company Information
  3. 8.1.2 Invertin Biotech Business Overview
  4. 8.1.3 Invertin Biotech Nicotinamide Riboside Malate Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Invertin Biotech Nicotinamide Riboside Malate Product Portfolio
  6. 8.1.5 Invertin Biotech Recent Developments
  7. 8.2 Xi'an Prius Biological Engineering Co.,Ltd
  8. 8.2.1 Xi'an Prius Biological Engineering Co.,Ltd Company Information
  9. 8.2.2 Xi'an Prius Biological Engineering Co.,Ltd Business Overview
  10. 8.2.3 Xi'an Prius Biological Engineering Co.,Ltd Nicotinamide Riboside Malate Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Xi'an Prius Biological Engineering Co.,Ltd Nicotinamide Riboside Malate Product Portfolio
  12. 8.2.5 Xi'an Prius Biological Engineering Co.,Ltd Recent Developments
  13. 8.3 Shenzhen Hygieia Biotechnology Co., Ltd
  14. 8.3.1 Shenzhen Hygieia Biotechnology Co., Ltd Company Information
  15. 8.3.2 Shenzhen Hygieia Biotechnology Co., Ltd Business Overview
  16. 8.3.3 Shenzhen Hygieia Biotechnology Co., Ltd Nicotinamide Riboside Malate Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shenzhen Hygieia Biotechnology Co., Ltd Nicotinamide Riboside Malate Product Portfolio
  18. 8.3.5 Shenzhen Hygieia Biotechnology Co., Ltd Recent Developments
  19. 8.4 Sihuan Pharmaceutical Holdings Group Ltd.
  20. 8.4.1 Sihuan Pharmaceutical Holdings Group Ltd. Company Information
  21. 8.4.2 Sihuan Pharmaceutical Holdings Group Ltd. Business Overview
  22. 8.4.3 Sihuan Pharmaceutical Holdings Group Ltd. Nicotinamide Riboside Malate Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sihuan Pharmaceutical Holdings Group Ltd. Nicotinamide Riboside Malate Product Portfolio
  24. 8.4.5 Sihuan Pharmaceutical Holdings Group Ltd. Recent Developments
  25. 8.5 NANJING NUOYUN BIOTECHNOLOGY CO.,LTD.
  26. 8.5.1 NANJING NUOYUN BIOTECHNOLOGY CO.,LTD. Company Information
  27. 8.5.2 NANJING NUOYUN BIOTECHNOLOGY CO.,LTD. Business Overview
  28. 8.5.3 NANJING NUOYUN BIOTECHNOLOGY CO.,LTD. Nicotinamide Riboside Malate Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 NANJING NUOYUN BIOTECHNOLOGY CO.,LTD. Nicotinamide Riboside Malate Product Portfolio
  30. 8.5.5 NANJING NUOYUN BIOTECHNOLOGY CO.,LTD. Recent Developments
  31. 8.6 Hubei Yanke Times Technology Co., Ltd.
  32. 8.6.1 Hubei Yanke Times Technology Co., Ltd. Company Information
  33. 8.6.2 Hubei Yanke Times Technology Co., Ltd. Business Overview
  34. 8.6.3 Hubei Yanke Times Technology Co., Ltd. Nicotinamide Riboside Malate Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hubei Yanke Times Technology Co., Ltd. Nicotinamide Riboside Malate Product Portfolio
  36. 8.6.5 Hubei Yanke Times Technology Co., Ltd. Recent Developments
  37. 8.7 Wuhan Hanxiang Biotechnology Co., Ltd.
  38. 8.7.1 Wuhan Hanxiang Biotechnology Co., Ltd. Company Information
  39. 8.7.2 Wuhan Hanxiang Biotechnology Co., Ltd. Business Overview
  40. 8.7.3 Wuhan Hanxiang Biotechnology Co., Ltd. Nicotinamide Riboside Malate Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Wuhan Hanxiang Biotechnology Co., Ltd. Nicotinamide Riboside Malate Product Portfolio
  42. 8.7.5 Wuhan Hanxiang Biotechnology Co., Ltd. Recent Developments
  43. 8.8 Bontac Bio-Engineering (Shenzhen) Co., Ltd.
  44. 8.8.1 Bontac Bio-Engineering (Shenzhen) Co., Ltd. Company Information
  45. 8.8.2 Bontac Bio-Engineering (Shenzhen) Co., Ltd. Business Overview
  46. 8.8.3 Bontac Bio-Engineering (Shenzhen) Co., Ltd. Nicotinamide Riboside Malate Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Bontac Bio-Engineering (Shenzhen) Co., Ltd. Nicotinamide Riboside Malate Product Portfolio
  48. 8.8.5 Bontac Bio-Engineering (Shenzhen) Co., Ltd. Recent Developments
  49. 8.9 Xi'an Chen Lang Biological Technology Co., Ltd.
  50. 8.9.1 Xi'an Chen Lang Biological Technology Co., Ltd. Company Information
  51. 8.9.2 Xi'an Chen Lang Biological Technology Co., Ltd. Business Overview
  52. 8.9.3 Xi'an Chen Lang Biological Technology Co., Ltd. Nicotinamide Riboside Malate Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Xi'an Chen Lang Biological Technology Co., Ltd. Nicotinamide Riboside Malate Product Portfolio
  54. 8.9.5 Xi'an Chen Lang Biological Technology Co., Ltd. Recent Developments
  55. 8.10 Wuhan Fortuna Chemical Co.,Ltd
  56. 8.10.1 Wuhan Fortuna Chemical Co.,Ltd Company Information
  57. 8.10.2 Wuhan Fortuna Chemical Co.,Ltd Business Overview
  58. 8.10.3 Wuhan Fortuna Chemical Co.,Ltd Nicotinamide Riboside Malate Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Wuhan Fortuna Chemical Co.,Ltd Nicotinamide Riboside Malate Product Portfolio
  60. 8.10.5 Wuhan Fortuna Chemical Co.,Ltd Recent Developments
  61. 8.11 Lucerna-Chem AG
  62. 8.11.1 Lucerna-Chem AG Company Information
  63. 8.11.2 Lucerna-Chem AG Business Overview
  64. 8.11.3 Lucerna-Chem AG Nicotinamide Riboside Malate Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Lucerna-Chem AG Nicotinamide Riboside Malate Product Portfolio
  66. 8.11.5 Lucerna-Chem AG Recent Developments
  67. 8.12 Gihi Chemicals
  68. 8.12.1 Gihi Chemicals Company Information
  69. 8.12.2 Gihi Chemicals Business Overview
  70. 8.12.3 Gihi Chemicals Nicotinamide Riboside Malate Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Gihi Chemicals Nicotinamide Riboside Malate Product Portfolio
  72. 8.12.5 Gihi Chemicals Recent Developments
  73. 8.13 Creative Enzymes
  74. 8.13.1 Creative Enzymes Company Information
  75. 8.13.2 Creative Enzymes Business Overview
  76. 8.13.3 Creative Enzymes Nicotinamide Riboside Malate Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Creative Enzymes Nicotinamide Riboside Malate Product Portfolio
  78. 8.13.5 Creative Enzymes Recent Developments
  79. 8.14 Bicells Science Ltd
  80. 8.14.1 Bicells Science Ltd Company Information
  81. 8.14.2 Bicells Science Ltd Business Overview
  82. 8.14.3 Bicells Science Ltd Nicotinamide Riboside Malate Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Bicells Science Ltd Nicotinamide Riboside Malate Product Portfolio
  84. 8.14.5 Bicells Science Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nicotinamide Riboside Malate Value Chain Analysis
  2. 9.1.1 Nicotinamide Riboside Malate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nicotinamide Riboside Malate Sales Mode & Process
  6. 9.2 Nicotinamide Riboside Malate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nicotinamide Riboside Malate Distributors
  9. 9.2.3 Nicotinamide Riboside Malate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst